Guangdong HEC Pharma wins China NMPA approval for insulin degludec injectionPUBT·14 hours ago06887-0.20%
Guangdong HEC Pharma controlling shareholder Zhang lifts stake to 51.42% after buying 1,451,400 H shares for HK$56 millionPUBT·15 hours ago06887-0.20%
Guangdong HEC Pharma files HKEX next-day return disclosing share repurchase at HKD 33.82PUBT·Jul 27 at 07:07 AM06887-0.20%
Hong Kong Niche Stocks Diverge on Earnings Surprises as Commodity, Tech ETFs Track VolatilityGlobal Report·Jul 26 at 04:18 AM099380.00%06887-0.20%
Corporate Buybacks and Macro Hedging: Industry Leaders Signal Valuation Floors Amid UncertaintyGlobal Report·Jul 26 at 04:14 AM01898-1.74%06887-0.20%
The Barbell Reality of Hong Kong Equities: Global Aggregators vs. Local SurvivorsGlobal Report·Jul 25 at 04:13 AM015610.00%06887-0.20%
Guangdong HEC Pharma files HKEX next-day disclosure return on share repurchase at HKD 32.34PUBT·Jul 24 at 05:40 AM06887-0.20%
The stark reality of Hong Kong’s forgotten equities in 2026Global Report·Jul 24 at 04:13 AM06887-0.20%00010-0.29%
Sunshine Lake Pharma Chairman Boosts Stake as Company Launches Share BuybackTip Ranks·Jul 20 at 10:08 AM06887-0.20%
Guangdong HEC Pharma controlling shareholder Zhang Yushuai holds 51.11% stake, plans HK$300 million-HK$600 million share buy-upPUBT·Jul 20 at 09:46 AM06887-0.20%
Sunshine Lake Pharma Backs RMB2 Billion Healthcare and AI Venture FundTip Ranks·Jun 26 at 10:19 AM600673+10.01%06887-0.20%
Sunshine Lake Pharma to buy Zhejiang industrial land use rights for RMB 26.55 millionPUBT·Jun 26 at 09:46 AM06887-0.20%
Sunshine Lake Pharma Wins Hong Kong Approval for Full H Share CirculationTip Ranks·May 6 at 05:08 AM06887-0.20%513700+0.69%
